P53 gene mutations: Case study of a clinical marker for solid tumors
- 1 June 2002
- journal article
- review article
- Published by Elsevier in Seminars in Oncology
- Vol. 29 (3) , 246-257
- https://doi.org/10.1053/sonc.2002.32900
Abstract
No abstract availableKeywords
This publication has 79 references indexed in Scilit:
- p53 Gene Mutation and Protein Accumulation during Neoplastic Progression in Barrett's EsophagusLaboratory Investigation, 2001
- p53 Alteration in regional lymph node metastases from prostate carcinomaCancer, 1999
- An evaluation of the markers p53 and Ki-67 for their predictive value in prostate cancerJournal of Surgical Oncology, 1998
- Diagnostic value of p53 immunohistochemistry in Barrett's esophagus: An endoscopic studyPathology, 1998
- Tumor angiogenesis and biologic markers in resected stage I NSCLCEuropean Journal of Cardio-Thoracic Surgery, 1997
- TP53 mutations in prostatic cancer. Analysis of pre‐ and post‐treatment archival formalin‐fixed tumour tissueThe Journal of Pathology, 1995
- MDM2 and CDK4 gene amplification in Ewing's sarcomaThe Journal of Pathology, 1995
- p53 Status and the Efficacy of Cancer Therapy in VivoScience, 1994
- Proliferating cell nuclear antigen and p53 expression as prognostic factors in T1‐2MO prostatic adenocarcinomaInternational Journal of Cancer, 1994
- Association of Multiple Copies of the N-mycOncogene with Rapid Progression of NeuroblastomasNew England Journal of Medicine, 1985